Publikationen, an denen er mitarbeitet Nicolás Navasa Mayo (3)

2018

  1. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis

    Cell Death and Disease, Vol. 9, Núm. 10

2017

  1. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis

    Gastroenterology, Vol. 152, Núm. 6, pp. 1449-1461.e7

  2. The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury

    Nature Communications, Vol. 8, Núm. 1